Lan Chen Selected Research

Neoplasm Antigens (Tumor Antigens)

10/2022	HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity.
2/2014	Maraba virus as a potent oncolytic vaccine vector.
4/2013	HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lan Chen Research Topics

Disease

56	Neoplasms (Cancer) 04/2024 - 01/2002
19	Infections 04/2024 - 11/2008
13	Inflammation (Inflammations) 11/2023 - 11/2002
12	Hypertension (High Blood Pressure) 12/2023 - 02/2005
11	COVID-19 02/2024 - 01/2020
8	Stroke (Strokes) 01/2023 - 08/2015
7	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 09/2006
6	Melanoma (Melanoma, Malignant) 01/2021 - 02/2014
6	Prion Diseases (Transmissible Spongiform Encephalopathies) 09/2007 - 08/2005
5	Parkinson Disease (Parkinson's Disease) 04/2024 - 02/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 08/2005
5	Breast Neoplasms (Breast Cancer) 12/2023 - 02/2012
5	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2017
5	Fibrosis (Cirrhosis) 01/2023 - 06/2019
5	Ischemic Stroke 01/2023 - 07/2017
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 07/2016
5	Body Weight (Weight, Body) 11/2022 - 10/2012
5	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 09/2003
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 09/2006
4	Acute Kidney Injury (Acute Renal Failure) 12/2024 - 01/2022
4	Communicable Diseases (Infectious Diseases) 04/2024 - 06/2005
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2023 - 12/2012
4	Squamous Cell Carcinoma of Head and Neck 10/2023 - 01/2020
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 06/2017
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2022 - 10/2017
4	Scrapie 09/2007 - 03/2004
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 01/2015
3	Dementia (Dementias) 10/2023 - 01/2023
3	Hypoxia (Hypoxemia) 10/2023 - 12/2020
3	Insulin Resistance 01/2023 - 10/2012
3	Lung Neoplasms (Lung Cancer) 01/2023 - 02/2004
3	Colitis 01/2023 - 01/2013
3	Adenocarcinoma 01/2023 - 01/2002
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 11/2021
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2005
3	Necrosis 01/2022 - 01/2017
3	Liver Cirrhosis (Hepatic Cirrhosis) 05/2021 - 02/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2018
3	Endometrial Neoplasms (Endometrial Cancer) 11/2018 - 01/2015
3	Prostatic Neoplasms (Prostate Cancer) 08/2006 - 12/2003
2	Asthma (Bronchial Asthma) 04/2024 - 01/2021
2	Diabetes Complications 10/2023 - 10/2022
2	Critical Illness (Critically Ill) 10/2023 - 12/2022
2	Cough 01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2006
12	VaccinesIBA 01/2024 - 11/2007
11	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 02/2005
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2019
8	AntigensIBA 02/2024 - 05/2009
8	DNA (Deoxyribonucleic Acid)IBA 05/2016 - 12/2003
6	Messenger RNA (mRNA)IBA 12/2022 - 01/2013
6	SaltsIBA 02/2022 - 12/2006
5	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2017
4	AntibodiesIBA 04/2024 - 01/2022
4	LipidsIBA 12/2023 - 01/2020
4	CytokinesIBA 11/2023 - 09/2011
4	Air Pollutants (Pollutants, Air)IBA 11/2023 - 04/2022
4	entinostat (MS 275)IBA 10/2023 - 04/2013
4	EnzymesIBA 10/2023 - 06/2004
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2019
4	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2013
3	Immunoglobulin G (IgG)IBA 04/2024 - 01/2022
3	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2021
3	InterferonsIBA 12/2023 - 01/2023
3	EpitopesIBA 12/2023 - 10/2021
3	Particulate MatterIBA 11/2023 - 01/2022
3	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2022
3	Histone Deacetylase InhibitorsIBA 10/2023 - 04/2013
3	Interleukin-17 (Interleukin 17)IBA 10/2023 - 01/2021
3	Peptides (Polypeptides)IBA 10/2023 - 01/2011
3	Sulfonic AcidsIBA 01/2023 - 01/2013
3	Circular RNAIBA 01/2023 - 01/2020
3	sym-trinitrobenzeneIBA 01/2023 - 01/2013
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2005
3	Neoplasm Antigens (Tumor Antigens)IBA 10/2022 - 04/2013
3	Complement C3 (C3 Complement)IBA 01/2022 - 12/2018
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2019
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2020 - 12/2006
3	oxidized low density lipoproteinIBA 01/2020 - 02/2005
3	Amyloid (Amyloid Fibrils)IBA 04/2014 - 01/2011
3	HDL CholesterolIBA 12/2005 - 02/2005
2	OzoneIBA 04/2024 - 04/2022
2	BilirubinIBA 03/2024 - 03/2016
2	Neutralizing AntibodiesIBA 03/2024 - 01/2012
2	Nylons (Nylon)IBA 01/2024 - 01/2022
2	CollagenIBA 12/2023 - 11/2020
2	Inactivated VaccinesIBA 12/2023 - 12/2023
2	AcidsIBA 10/2023 - 02/2022
2	Agammaglobulinaemia Tyrosine KinaseIBA 07/2023 - 01/2022
2	Chimeric Antigen ReceptorsIBA 07/2023 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2023 - 12/2020

Therapy/Procedure

29	Therapeutics 04/2024 - 07/2007
10	Immunotherapy 10/2023 - 03/2013
5	Drug Therapy (Chemotherapy) 12/2023 - 01/2002
4	Radiotherapy 01/2023 - 01/2002
4	Extracorporeal Membrane Oxygenation 06/2022 - 04/2015
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2019
3	Activities of Daily Living (ADL) 01/2023 - 01/2022
2	Aftercare (After-Treatment) 01/2024 - 01/2022
2	Photothermal Therapy 12/2023 - 10/2023